Agency Forms Undergoing Paperwork Reduction Act Review, 36144-36146 [2017-16333]
Download as PDF
<![CDATA[
36144
Federal Register / Vol. 82, No. 148 / Thursday, August 3, 2017 / Notices
revised estimates reflect input obtained
by the EEOC during a limited survey of
school districts with varying resource
levels and student populations. The
school districts provided information on
the types of employees that participate
in preparation of the EEO–5 report and
the amount of time spent by each type
of employee. After accounting for the
time spent by the various employees
who have a role in preparing an EEO–
5, the EEOC estimates that a school
district will spend 17.07 hours to
prepare the report, and estimates that
the aggregate biennial hour burden for
all respondents is 102,839.32. The cost
associated with the burden hours was
calculated using median hourly wage
rates obtained from the Department of
Labor 2 for each job identified above as
participating in the submission of the
survey; the burden hour cost per school
district will be approximately $539.57,
while the estimated total biennial
burden cost for all 6024 school districts
will be $3,250,361.25 (See Table 1 3).
TABLE 1—ESTIMATE OF BURDEN FOR EEO–5 REPORT
Hourly
wage rate
Burden hours
per district
Burden hour
cost per
district 4
Total burden
hours 5
Total burden
hour cost 6
N = 6024
COMPUTER SUPPORT SPECIALIST (IT PROFESSIONAL/DATA PROCESSING SPECIALIST) .................
DIRECTOR OF SCHOOL FINANCE (FINANCIAL MANAGERS) ............................................................................
EXECUTIVE CLERICAL STAFF .........................................
HUMAN RESOURCE SPECIALIST ....................................
PAYROLL SPECIALIST .......................................................
SENIOR HUMAN RESOURCE MANAGERS ......................
SUPERINTENDENT (SCHOOL MANAGEMENT OCCUPATIONS ..........................................................................
SUB TOTAL ..................................................................
These estimates are based on an
assumption of paper reporting.
However, the EEOC has made electronic
filing much easier for respondents
required to file the EEO–5 Report. As a
result, more respondents are using this
filing method. This development, along
with the greater availability of human
resource information software, is
expected to significantly reduce the
actual burden of reporting. The
Commission continues to develop more
reliable estimates of reporting burdens
given the significant increase in
electronic filing and explore new
approaches to make such reporting even
less burdensome. In order to help
reduce survey burden, respondents are
encouraged to report data electronically,
whenever possible.
Dated: July 24, 2017.
For the Commission.
Victoria A. Lipnic,
Acting Chair.
[FR Doc. 2017–16340 Filed 8–2–17; 8:45 am]
mstockstill on DSK30JT082PROD with NOTICES
BILLING CODE 6570–01–P
2 Median hourly wage rates were obtained from
the Bureau of Labor Statistics (see U.S. Dept. of
Labor, Bureau of Labor Statistics, Occupational
Outlook Handbook, https://www/bls.gov/ooh/)
3 Figures shown in table have been rounded.
VerDate Sep<11>2014
16:35 Aug 02, 2017
Jkt 241001
25.21
3.4286
86.4343
20653.7143
520680.1371
56.73
26.66
28.06
20.26
50.21
0.1429
2.9286
5.4286
1.4286
3.4286
8.1043
78.0757
152.3257
28.9429
172.1486
860.5714
17641.7143
32701.7143
8605.7143
20653.7143
48820.2171
470328.1029
917610.1029
174351.7714
1037022.9943
47.38
0.2857
13.5371
1721.1429
81547.7486
........................
17.0716
539.5686
102839.3184
3250361.2464
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the offices of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than August
17, 2017.
A. Federal Reserve Bank of
Minneapolis (Brendan S. Murrin,
Assistant Vice President) 90 Hennepin
Avenue, Minneapolis, Minnesota
55480–0291:
1. Boyd Brent Myers, Tazewell,
Tennessee, as trustee of six McNeilus
4 The figures in this column were calculated by
multiplying the figures in the Hourly Wage Rate
column by those in the Burden Hours Per District
Column.
5 The figures in this column were calculated by
multiplying the figures in the Burden Hours Per
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
family trusts, all of Rochester,
Minnesota; to retain control of the
voting shares of Sterling Financial
Group, Inc., Rochester, Minnesota, and
thereby indirectly retain control of
Sterling State Bank, Austin, Minnesota.
Board of Governors of the Federal Reserve
System, July 28, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017–16292 Filed 8–2–17; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–17–0576]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
District column by 6024, the total number of
respondents.
6 The figures in this column were calculated by
multiplying the figures in the Burden Hour Cost Per
District column by 6024, the total number of
respondents.
E:\FR\FM\03AUN1.SGM
03AUN1
36145
Federal Register / Vol. 82, No. 148 / Thursday, August 3, 2017 / Notices
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Possession, Use, and Transfer of
Select Agents and Toxins (42 CFR part
73)—Revision—Centers for Disease
Control and Prevention (CDC)/Division
of Select Agents and Toxins (DSAT) and
United States Department of Agriculture
(USDA) Animal and Plant Health
Inspection Service (APHIS)/Agriculture
Select Agent Services (AgSAS).
Background and Brief Description
Subtitle A of the Public Health
Security and Bioterrorism Preparedness
and Response Act of 2002, (42 U.S.C.
262a), requires the United States
Department of Health and Human
Services (HHS) to regulate the
possession, use, and transfer of
biological agents or toxins that have the
potential to pose a severe threat to
public health and safety (select agents
and toxins). Subtitle B of the Public
Health Security and Bioterrorism
Preparedness and Response Act of 2002
(which may be cited as the Agricultural
Bioterrorism Protection Act of 2002), (7
U.S.C. 8401), requires USDA to regulate
the possession, use, and transfer of
biological agents or toxins that have the
potential to pose a severe threat to
animal or plant health, or animal or
plant products (select agents and
toxins). The HHS Secretary delegated
the responsibility for promulgating and
implementing select agent regulations
found at 42 CFR part 73 to CDC Division
of Select Agents and Toxins (DSAT).
The United States Department of
Agriculture (USDA) Animal and Plant
Health Inspection Service (APHIS)/
Agriculture Select Agent Services
(AgSAS) was delegated responsibility by
USDA for select agent regulations (7
CFR part 331, and 9 CFR part 121). The
Federal Select Agent Program (FSAP) is
the collaboration of the DSAT and
AgSAS to administer the select agent
regulations in a manner to minimize the
administrative burden on persons
subject to the select agent regulations.
Accordingly, CDC and APHIS have
adopted an identical system to collect
information for the possession, use, and
transfer of select agents and toxins.
CDC is requesting OMB approval to
revise the collected information under
the select agent regulations through the
use of the APHIS/CDC Form 3 (Incident
Notification and Reporting (Theft/Loss/
Release)). The form (42 CFR 73.19(a),(b))
must be completed by an individual or
an entity whenever the individual or
entity experiences a theft, loss, or
release of a select agent or toxin. CDC
is proposing to revise the form to further
clarify what needs to be reported as a
‘‘release’’ and ‘‘loss’’ and additional
fields to assist with categorizing the
type of release (e.g., spill within
secondary containment, occupational
exposure, possible breach of facility
containment, etc.), type of exposure,
and the understanding of safety and
security risk levels relative to human
illness. Guidance documents were also
added to assist with the following
forms: Application for Registration
(APHIS/CDC Form 1), Request to
Transfer Select Agents and Toxins
(APHIS/CDC Form 2), Report of
Identification of a Select Agent or Toxin
(APHIS/CDC Form 4), Request of
Exemption of Select Agents and Request
for Exclusions Toxins for an
Investigational Product (APHIS/CDC
Form 5), Request for Expedited Review,
Security Plan, Security Plan, Biosafety
Plan, Request Regarding a Restricted
Experiment, Incident Response Plan,
Training, and Records.
Annualized burden hours and cost
were calculated based on data obtained
from 2016 Annual Report of the Federal
Select Agent Program for submissions to
FSAP for 2016. CDC requests a three
year approval for this Revision. The
estimated annualized Burden has been
reduced to 8,408 hours due to the
decrease in the number of Respondents.
There is no cost to Respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
73.7 ...................
73.7 ...................
73.7 ...................
73.16 .................
73.16 .................
mstockstill on DSK30JT082PROD with NOTICES
Section
Application for Registration (APHIS/CDC Form 1) ......................................
Amendment to a Certificate of Registration ................................................
Application for Registration (APHIS/CDC Form 1) Guidance .....................
Request to Transfer Select Agents and Toxins (APHIS/CDC Form 2) ......
Request to Transfer Select Agents and Toxins (APHIS/CDC Form 2)
Guidance.
Report of Theft, Loss, or Release of Select Agent or Toxin (APHIS/CDC
Form 3).
Report of Theft, Loss, or Release of Select Agent or Toxin (APHIS/CDC
Form 3) Guidance.
Report of Identification of a Select Agent or Toxin from a Clinical/Diagnostic Specimen (APHIS/CDC Form 4A).
Report of Identification of a Select Agent or Toxin from a Proficiency Test
(APHIS/CDC Form 4B).
73.19 .................
73.19 .................
73.5 & 6 .............
73.5 & 6 .............
VerDate Sep<11>2014
16:35 Aug 02, 2017
Jkt 241001
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
E:\FR\FM\03AUN1.SGM
Number of
responses per
respondent
Average
burden per
response
(in hours)
1
238
1
188
188
1
7
1
1
1
4
1
1
1
30/60
205
1
90/60
205
1
30/60
1,030
1
30/60
10
1
30/60
03AUN1
36146
Federal Register / Vol. 82, No. 148 / Thursday, August 3, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
73.5 & 6 .............
Federal Law Enforcement Reporting Seizure of Select Agent or Toxin
(APHIS/CDC Form 4C).
Report of Identification of a Select Agent or Toxin (APHIS/CDC Form 4)
Guidance.
Request of Exemption of Select Agents and Toxins for an Investigational
Product (APHIS/CDC Form 5).
Request of Exemption of Select Agents and Toxins for an Investigational
Product (APHIS/CDC Form 5) Guidance.
Request for Exclusions ................................................................................
Request for Exclusions Guidance ...............................................................
Documentation of Self-inspection ................................................................
Request for Expedited Review ....................................................................
Request for Expedited Review Guidance ....................................................
Security Plan ................................................................................................
Security Plan Guidance ...............................................................................
Security Plan Template ................................................................................
Biosafety Plan ..............................................................................................
Biosafety Plan Guidance .............................................................................
Biosafety Plan Template ..............................................................................
Request Regarding a Restricted Experiment ..............................................
Request Regarding a Restricted Experiment Guidance .............................
Incident Response Plan ...............................................................................
Incident Response Plan Guidance ..............................................................
Incident Response Plan Template ...............................................................
Training ........................................................................................................
Training Guidance ........................................................................................
Records ........................................................................................................
Guidance on the Inventory of Select Agents ...............................................
Administrative Review ..................................................................................
73.5 & 6 .............
73.5 & 73.6 ........
73.5 & 73.6 ........
73.3 & 73.4 ........
73.3 & 73.4 ........
73.9 ...................
73.1 ...................
73.1 ...................
73.11 .................
73.11 .................
73.11 .................
73.12 .................
73.12 .................
73.12 .................
73.13 .................
73.13 .................
73.14 .................
73.14 .................
73.14 .................
73.15 .................
73.15 .................
73.17 .................
73.17 .................
73.20 .................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–16333 Filed 8–2–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2014–0015]
Vaccines Adverse Event Reporting
System (VAERS) 2.0 Form
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
mstockstill on DSK30JT082PROD with NOTICES
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS) announces the
availability of the final Vaccines
Adverse Event Reporting System
(VAERS) 2.0 Form www.vaers.hhs.gov.
The VAERS 2.0 Form replaces the
SUMMARY:
VerDate Sep<11>2014
16:35 Aug 02, 2017
Jkt 241001
VAERS–1 Form which had been in use
since 1990.
DATES: The VAERS 2.0 Form was
implemented June 30, 2017.
FOR FURTHER INFORMATION CONTACT:
Tiffany Suragh, National Center for
Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control
and Prevention, 1600 Clifton Road NE.,
Mailstop D–26; Atlant, Georgia 30329–
4018; Telephone: (404) 498–0681.
SUPPLEMENTARY INFORMATION: VAERS is
an important and critical ‘‘early warning
system’’ in the federal vaccine safety
infrastructure for identifying adverse
events after receipt of childhood,
adolescent, and adult vaccines licensed
for use in the United States. Healthcare
providers and vaccine manufacturers
are required under section 2125(b) of
the Public Health Service Act (42 U.S.C.
300aa–25(b)) to submit VAERS reports
regarding the occurrence of any event
set forth in the Vaccine Injury Table
which occurs within 7 days of the
administration of any vaccine set forth
in the Table or within such longer
period as is specified in the Table and
the occurrence of any contraindicating
reaction to a vaccine which is specified
in the manufacturer’s package insert.
VAERS also accepts reports on adverse
events following receipt of other
PO 00000
Frm 00033
Number of
responses per
respondent
Number of
respondents
Section
Fmt 4703
Sfmt 4703
Average
burden per
response
(in hours)
1
1
30/60
1,030
1
30/60
1
1
30/60
1
1
30/60
3
3
238
1
1
238
238
238
238
238
238
1
1
238
238
238
238
238
238
238
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
30/60
30/60
1
15/60
15/60
5
30/60
30/60
5
30/60
30/60
30/60
30/60
5
30/60
30/60
30/60
30/60
30/60
30/60
1
vaccines. Patients, parents and others
aware of adverse events can also submit
VAERS reports. Although VAERS is not
designed to assess if a vaccine caused an
adverse event, VAERS provides HHS/
CDC and HHS/FDA with important
early information that might signal a
potential problem. If the VAERS data
suggest a possible association between
an adverse event and vaccination, the
relationship will be further assessed. In
recent years VAERS has received
approximately 40,000 U.S. reports
annually.
VAERS is a mandated activity for the
Department of Health and Human
Services (HHS) and VAERS data are
used by Federal agencies, State Health
Officials, health care providers,
manufacturers, and the public.
Therefore, it is important to maximize
the usefulness of this system. The
information collected by the final
VAERS 2.0 Form will be similar to that
from the current VAERS–1 Form so
historical comparisons can be made.
However, the changes in the final
VAERS 2.0 Form should improve
reporting efficiency and data quality.
VAERS 2.0 Form offers standardized
responses, clearer instructions and
guidance, and improved online
reporting capability. Select questions
E:\FR\FM\03AUN1.SGM
03AUN1
]]>Agencies
[Federal Register Volume 82, Number 148 (Thursday, August 3, 2017)]
[Notices]
[Pages 36144-36146]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16333]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-17-0576]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is
[[Page 36145]]
published to obtain comments from the public and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Possession, Use, and Transfer of Select Agents and Toxins (42 CFR
part 73)--Revision--Centers for Disease Control and Prevention (CDC)/
Division of Select Agents and Toxins (DSAT) and United States
Department of Agriculture (USDA) Animal and Plant Health Inspection
Service (APHIS)/Agriculture Select Agent Services (AgSAS).
Background and Brief Description
Subtitle A of the Public Health Security and Bioterrorism
Preparedness and Response Act of 2002, (42 U.S.C. 262a), requires the
United States Department of Health and Human Services (HHS) to regulate
the possession, use, and transfer of biological agents or toxins that
have the potential to pose a severe threat to public health and safety
(select agents and toxins). Subtitle B of the Public Health Security
and Bioterrorism Preparedness and Response Act of 2002 (which may be
cited as the Agricultural Bioterrorism Protection Act of 2002), (7
U.S.C. 8401), requires USDA to regulate the possession, use, and
transfer of biological agents or toxins that have the potential to pose
a severe threat to animal or plant health, or animal or plant products
(select agents and toxins). The HHS Secretary delegated the
responsibility for promulgating and implementing select agent
regulations found at 42 CFR part 73 to CDC Division of Select Agents
and Toxins (DSAT). The United States Department of Agriculture (USDA)
Animal and Plant Health Inspection Service (APHIS)/Agriculture Select
Agent Services (AgSAS) was delegated responsibility by USDA for select
agent regulations (7 CFR part 331, and 9 CFR part 121). The Federal
Select Agent Program (FSAP) is the collaboration of the DSAT and AgSAS
to administer the select agent regulations in a manner to minimize the
administrative burden on persons subject to the select agent
regulations. Accordingly, CDC and APHIS have adopted an identical
system to collect information for the possession, use, and transfer of
select agents and toxins.
CDC is requesting OMB approval to revise the collected information
under the select agent regulations through the use of the APHIS/CDC
Form 3 (Incident Notification and Reporting (Theft/Loss/Release)). The
form (42 CFR 73.19(a),(b)) must be completed by an individual or an
entity whenever the individual or entity experiences a theft, loss, or
release of a select agent or toxin. CDC is proposing to revise the form
to further clarify what needs to be reported as a ``release'' and
``loss'' and additional fields to assist with categorizing the type of
release (e.g., spill within secondary containment, occupational
exposure, possible breach of facility containment, etc.), type of
exposure, and the understanding of safety and security risk levels
relative to human illness. Guidance documents were also added to assist
with the following forms: Application for Registration (APHIS/CDC Form
1), Request to Transfer Select Agents and Toxins (APHIS/CDC Form 2),
Report of Identification of a Select Agent or Toxin (APHIS/CDC Form 4),
Request of Exemption of Select Agents and Request for Exclusions Toxins
for an Investigational Product (APHIS/CDC Form 5), Request for
Expedited Review, Security Plan, Security Plan, Biosafety Plan, Request
Regarding a Restricted Experiment, Incident Response Plan, Training,
and Records.
Annualized burden hours and cost were calculated based on data
obtained from 2016 Annual Report of the Federal Select Agent Program
for submissions to FSAP for 2016. CDC requests a three year approval
for this Revision. The estimated annualized Burden has been reduced to
8,408 hours due to the decrease in the number of Respondents. There is
no cost to Respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Section Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
73.7........................... Application for Registration 1 1 4
(APHIS/CDC Form 1).
73.7........................... Amendment to a Certificate of 238 7 1
Registration.
73.7........................... Application for Registration 1 1 1
(APHIS/CDC Form 1) Guidance.
73.16.......................... Request to Transfer Select 188 1 1
Agents and Toxins (APHIS/CDC
Form 2).
73.16.......................... Request to Transfer Select 188 1 30/60
Agents and Toxins (APHIS/CDC
Form 2) Guidance.
73.19.......................... Report of Theft, Loss, or 205 1 90/60
Release of Select Agent or
Toxin (APHIS/CDC Form 3).
73.19.......................... Report of Theft, Loss, or 205 1 30/60
Release of Select Agent or
Toxin (APHIS/CDC Form 3)
Guidance.
73.5 & 6....................... Report of Identification of a 1,030 1 30/60
Select Agent or Toxin from a
Clinical/Diagnostic Specimen
(APHIS/CDC Form 4A).
73.5 & 6....................... Report of Identification of a 10 1 30/60
Select Agent or Toxin from a
Proficiency Test (APHIS/CDC
Form 4B).
[[Page 36146]]
73.5 & 6....................... Federal Law Enforcement 1 1 30/60
Reporting Seizure of Select
Agent or Toxin (APHIS/CDC Form
4C).
73.5 & 6....................... Report of Identification of a 1,030 1 30/60
Select Agent or Toxin (APHIS/
CDC Form 4) Guidance.
73.5 & 73.6.................... Request of Exemption of Select 1 1 30/60
Agents and Toxins for an
Investigational Product (APHIS/
CDC Form 5).
73.5 & 73.6.................... Request of Exemption of Select 1 1 30/60
Agents and Toxins for an
Investigational Product (APHIS/
CDC Form 5) Guidance.
73.3 & 73.4.................... Request for Exclusions......... 3 1 30/60
73.3 & 73.4.................... Request for Exclusions Guidance 3 1 30/60
73.9........................... Documentation of Self- 238 1 1
inspection.
73.1........................... Request for Expedited Review... 1 1 15/60
73.1........................... Request for Expedited Review 1 1 15/60
Guidance.
73.11.......................... Security Plan.................. 238 1 5
73.11.......................... Security Plan Guidance......... 238 1 30/60
73.11.......................... Security Plan Template......... 238 1 30/60
73.12.......................... Biosafety Plan................. 238 1 5
73.12.......................... Biosafety Plan Guidance........ 238 1 30/60
73.12.......................... Biosafety Plan Template........ 238 1 30/60
73.13.......................... Request Regarding a Restricted 1 1 30/60
Experiment.
73.13.......................... Request Regarding a Restricted 1 1 30/60
Experiment Guidance.
73.14.......................... Incident Response Plan......... 238 1 5
73.14.......................... Incident Response Plan Guidance 238 1 30/60
73.14.......................... Incident Response Plan Template 238 1 30/60
73.15.......................... Training....................... 238 1 30/60
73.15.......................... Training Guidance.............. 238 1 30/60
73.17.......................... Records........................ 238 1 30/60
73.17.......................... Guidance on the Inventory of 238 1 30/60
Select Agents.
73.20.......................... Administrative Review.......... 1 1 1
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-16333 Filed 8-2-17; 8:45 am]
BILLING CODE 4163-18-P
